Wellness-linked insurance: validated engagement, annual screening, and disease management — turning co-payments & premium hikes from a complaint into an incentive policyholders control themselves.

The problem
Double-digit medical inflation is only half the story — individual health products carry four structural diseases group policies don't.
The keenest buyers are those who expect to claim — the pool tilts toward bad risk from day one.
Premiums rise → healthy members leave → the pool worsens → premiums rise again. Every renewal.
Nothing stands between the first symptom and a large hospital bill.
You meet policyholders only at billing and at claims — with no instrument to change the risk itself.
The 2026 moment
New indemnity health products must apply a minimum 10% co-payment from 2026.
“My premium went up — why do I still pay at claim time?” — a new sales friction across the industry.
The first insurer whose policyholders can lower their own co-payment wins the retail market.
10%
minimum co-payment on new indemnity products — 2026
The same burden for every player — the differentiator is who turns it into an incentive.
The core idea
A score built from validated activity (GPS, pedometer, pace — anti-cheat), Nutrico+ habits, and annual screening — not just opening an app.
A high score lowers the co-payment — say from 10% to 5% or 0%. Funded from the expected claims savings.
The annual score sets next year's cashback/discount — a strong reason for healthy members to stay in the pool.
The program
LAYER 1
Every policyholder
PMPM fee per active policy
LAYER 2
Early detection for everyone
Per screening · facility volume
LAYER 3
The highest-risk 5–10%
Shared savings vs control
Layer allocation follows claims data + screening results — the small cohort behind most claims gets the deepest intervention.
The economics
An illustration for a 10,000-policy retail cohort (avg premium Rp 5m/year, 100% claim ratio): program cost ±Rp 2.4bn/year. A −10% claims scenario nets ±Rp 2.6bn/year — before persistency & risk-selection effects.
An illustration — not a projection. Actual figures are computed with your actuarial team from your cohort's data; the pilot phase uses a flat PMPM fee, with shared savings activating only once the delta is proven.
Rp 2,4 M
program cost / year
Rp 2,5 M
saved @ claims −5%
Rp 5,0 M
saved @ claims −10%
Rp 7,5 M
saved @ claims −15%
Not a reporting vendor. Livewell partners with Plebo's healthcare facilities — OneLab by Plebo & Medias by Plebo — so risk isn't just measured, it's actually reduced. That's what moves your client's loss ratio.


Accredited Plebo partner facilities

The diagnostics that produce the data — not just a dashboard.

Clinicians who follow through on findings, not just charts.

We come to the workplace, across industries.

A main clinic licensed through 2028 — MCU, clinical lab & home care, connected to the AdMedika, Medika Plaza, Fullerton Health & BRI Life networks.

20,000+
employees served across manufacturing, garment & enterprise
10,700
employees screened in a single on-site MCU engagement
≈ 20%
insurance claim-ratio reduction (AHM program)
4 years
building an integrated prevention + wellness platform
Trust & compliance
In retail, individual data is used with the policyholder's explicit consent — they're the one enjoying the incentive. Portfolio analytics stay aggregate & anonymous.
Wellness-linked insurance already runs in many markets — this is not an experimental concept.
Audit trails, role-based access control, and a measurement methodology agreed up front with your actuaries.
Incentives are tied to validated activity + screening results — not cosmetic engagement that can be gamed.
How to start
One closed cohort (5–10k policies). Engagement + screening + renewal cashback. Flat PMPM fee — your risk stays bounded.
Claims delta proven → scale up, with dynamic co-payment relief & disease management on a shared-savings scheme.
Renewal premiums tied to the Health Score — filed as a new product after two phases of actuarial evidence.
Bring your actuaries — we'll bring our corporate program data, the pilot design, and the clinical network. One half-day workshop is enough to decide whether a pilot is worth running.